Article Text

Download PDFPDF
Review Article: Sexuality and Risk-Reducing Salpingo-oophorectomy
  1. Paige E. Tucker, MBBS, BSc*, and
  2. Paul A. Cohen, MD, FRANZCOG*,,§
  1. * St John of God Hospital Bendat Family Comprehensive Cancer Centre, Subiaco;
  2. School of Medicine and
  3. Institute for Health Research, University of Notre Dame, Fremantle; and
  4. § School of Women’s and Infants’ Health, University of Western Australia, Subiaco, Western Australia, Australia.
  1. Address correspondence and reprint requests to Paige E. Tucker, MBBS, BSc, St John of God Hospital Bendat Family Comprehensive Cancer Centre, 12 Salvado Rd, Subiaco, Western Australia 6008, Australia. E-mail: Paige.Tucker{at}


Introduction Women with familial cancer syndromes such as hereditary breast and ovarian cancer syndrome (BRCA1 and BRCA2) and Lynch syndrome are at a significantly increased risk of developing ovarian cancer and are advised to undergo prophylactic removal of their ovaries and fallopian tubes at age 35 to 40 years, after childbearing is complete.

Methods A comprehensive literature search of studies on risk-reducing salpingo-oophorectomy (RRSO), sexuality, and associated issues was conducted in MEDLINE databases.

Results Risk-reducing salpingo-oophorectomy can significantly impact on a woman’s psychological and sexual well-being, with women wishing they had received more information about this prior to undergoing surgery. The most commonly reported sexual symptoms experienced are vaginal dryness and reduced libido. Women who are premenopausal at the time of surgery may experience a greater decline in sexual function, with menopausal hormone therapy improving but not alleviating sexual symptoms. Pharmacological treatments including testosterone patches and flibanserin are available but have limited safety data in this group.

Conclusions Despite the high rates of sexual difficulties after RRSO, patient satisfaction with the decision to undergo surgery remains high. Preoperative counseling with women who are considering RRSO should include discussion of its potential sexual effects and the limitations of menopausal hormone therapy in managing symptoms of surgical menopause.

  • BRCA1/2
  • Lynch syndrome
  • Menopause
  • Risk-reducing salpingo-oophorectomy
  • Sexuality

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • The authors declare no conflicts of interest.